APGE- Apogee Therapeutics, Inc.

Across the last three months, Apogee Therapeutics, Inc.'s insiders have reduced their positions by a net 5,500 shares worth roughly $738K.

Classified under Biotechnology (Health Care sector), APGE's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Henderson Michael Thomas	920.9K	-	-
Other	Dambkowski Carl	168.5K	$22.61M	-
CFO	Henderson Jane	158.4K	-	-
Dir	Fairmount Funds Management LLC	7.7K	-	-
Dir	Bollinger Lisa	7.7K	-	-

Buys and sells only

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 5, 2025	Henderson Michael Thomas57	Chief Executive Officer	Sell	15,000	$40.58	$608,700.00	-1.1%	-13.9%	+50.3%
Jan 8, 2025	Henderson Michael Thomas57	Chief Executive Officer	Sell	15,000	$48.85	$732,692.88	-1.1%	-41.5%	+57.4%
Jan 2, 2025	Dambkowski Carl47	Chief Medical Officer	Sale+OE	4,085	$46.94	$191,739.64	-1.6%	-19.8%	+60.7%
Dec 12, 2024	McKenna Mark C.	Director	Buy	20,000	$49.54	$990,775.00	New	-13.1%	+73.9%
Dec 11, 2024	Dambkowski Carl47	Chief Medical Officer	Sale+OE	4,540	$48.76	$221,362.70	-1.7%	-17.4%	+56.9%
Dec 4, 2024	Henderson Michael Thomas57	Chief Executive Officer	Sell	15,000	$46.58	$698,653.68	-1.1%	-41.6%	+45.1%
Dec 4, 2024	Dambkowski Carl47	Chief Medical Officer	Sell	6,665	$46.07	$307,056.55	-2.5%	-41.6%	+45.1%
Nov 6, 2024	Henderson Michael Thomas57	Chief Executive Officer	Sell	15,000	$59.22	$888,320.00	-1.1%	-31.2%	-6.5%
Nov 6, 2024	Dambkowski Carl47	Chief Medical Officer	Sell	6,665	$59.12	$394,041.10	-2.4%	-31.2%	-6.5%
Oct 2, 2024	Dambkowski Carl47	Chief Medical Officer	Sell	6,665	$56.26	$374,953.90	-2.4%	-19.4%	-29.6%